Skip to main content

Table 2 Data set characteristics.

From: Large scale study of multiple-molecule queries

Name Size Reference
muv-chaperone 30 [25]
muv-gpcr-1 30 [25]
muv-gpcr-2 30 [25]
muv-gpcr-3 30 [25]
muv-kinase-1 30 [25]
muv-kinase-2 30 [25]
muv-kinase-3 30 [25]
muv-nr-1 30 [25]
muv-nr-2 30 [25]
muv-ppi-1 30 [25]
muv-ppi-2 30 [25]
muv-ppi-3 30 [25]
muv-protease-1 30 [25]
muv-protease-2 30 [25]
muv-protease-3 30 [25]
muv-rnase 30 [25]
muv-rtk 30 [25]
nci-hiv 415 [23]
stahl-cox2 125 [21]
stahl-estrogen 53 [21]
stahl-gelatinase 40 [21]
stahl-neuraminidase 17 [21]
stahl-p38-map-kinase 24 [21]
stahl-thrombin 67 [21]
suth-benzodiazepine 404 [22]
suth-dhfr 722 [22]
suth-estrogen 361 [22]
suth-steroid 28 [22]
wom-alr2 42 [20]
wom-androgen 36 [20]
wom-cdk2 152 [20]
wom-cox2 76 [20]
wom-d2 334 [20]
wom-egfr 74 [20]
wom-estrogen 64 [20]
wom-fxa 107 [20]
wom-hiv1rt 99 [20]
wom-impdh 49 [20]
wom-p38-map-kinase 59 [20]
wom-pde5 88 [20]
wom-ppar-gamma 27 [20]
  1. Each data set is given an abbreviated name and is listed with the the number of molecules and its reference. In the case of the the NCI HIV screen (nci-hiv) we use only the 415 confirmed actives and discard the inactive and moderately-active compounds.
Back to article page